Previous Blogs

Avatar

By Andy Polywacz

August 12, 2020

At West, we are committed to safeguarding the health and safety of the millions of patients who use our products every day. This commitment is anchored in our Core Value of Leadership in Quality, which ensures we never compromise on quality because we know that patients are counting on us.

Avatar

By Olga Laskina, Ph.D.

July 10, 2020

The overall quality of a final drug product depends on the components of its packaging and delivery systems.  The use of visually inspected components reduces the risk of defective components and helps ensure patient safety.

Avatar

By Marisa Leuzzi

September 06, 2019

West’s top priority is delivering high-quality products that meet the exact product specifications and quality standards customers require and expect in the interest of patient safety. This focus on quality includes excellence in manufacturing, scientific and technical expertise, and management. At the manufacturing level, this means producing clean, sterile, high-quality components to minimize disruptions to the supply chain and bringing safe, effective drug products to the market—and to the patient—quickly and efficiently.

Avatar

By Andy Polywacz

August 27, 2018

In the pharmaceutical and biopharmaceutical industry, customers are challenged with the need for higher quality product options and a flexible supply chain. Quality standards are everchanging, and to help customers meet regulatory filing complexity, West has developed next-generation quality for ready-to-sterilize (RS) and ready-to-use (RU) components in an effort to provide a solution for those challenges while establishing a new regulatory strategy designed for risk mitigation.

Avatar

By West's Global Communications Team

August 09, 2017

West is pleased to announce that the company has received the 2017 “Supplier of the Year in Quality Award” from long-time customer, Bristol-Myers Squibb (BMS). The award is based on West’s excellent performance in quality, along with our flawless quality track record and responsiveness with diligent site engagement.

Avatar

By Heike Kofler, Ph.D.

May 26, 2016

“There is no disease so rare that it does not deserve attention.” This statement from Orphanet, a portal for rare diseases and orphan drugs, makes that point very clearly. For patients suffering from a rare disease, orphan drugs and the special attention that they receive during the drug review and approval process can be both life changing and saving.